In 2025, the Dow Jones, S&P 500, and Nasdaq have seen double-digit gains. The Federal Reserve made history with a
Shiba Inu’s value has plummeted by 90% since its peak in 2021, despite efforts to boost interest in the coin
“Who Wants to Be a Millionaire?” may be a catchy TV game show, but investing in stocks like Alnylam Pharmaceuticals
The Metals Company is venturing into deep-sea mining, aiming to unlock a vast resource of metals for various industries. They
Many retirees rely on Medicare for affordable health coverage, but costs are increasing in 2026. The standard monthly premium for
Dogecoin’s value is based on perception, with 5 billion new Dogecoins mined annually and no supply limit. The past five
Viavi Solutions CEO Oleg Khaykin sold 73,442 shares in December 2025, totaling around $1.3 million. This represented 3.68% of his
Bitcoin’s prior all-time high was over $126,000, with a good chance of surpassing that in 2026 due to inflation concerns
Annaly Capital Management offers a 12% dividend yield, while Realty Income provides a 5.6% yield. Annaly, a mortgage REIT, focuses
Sprouts Farmers Market has experienced a rough 2025 in terms of stock performance, but operationally, the company has only grown
Ethereum has seen a significant rise and fall in price, hitting an all-time high of $4,954 in August before dropping
Current Social Security recipients will receive a 2.8% benefit boost in 2026, with the average increase in benefits being $56
Vertex Pharmaceuticals is a leader in cystic fibrosis treatment, with drugs that have generated significant revenue. The company has expanded
Eli Lilly is reducing the price of its weight loss drug, Zepbound, to improve access for patients without insurance coverage.
Shares of Lululemon Athletica (NASDAQ: LULU) have fluctuated due to macroeconomic challenges in recent years, leading to a modest valuation.
If you’re planning to retire in 2026, be prepared for potential inflation woes. Consider delaying your Social Security claim until
TScan Therapeutics, Inc. announced updated results from its ALLOHA Phase 1 trial, showing favorable relapse-free survival and overall survival in
Fulcrum Therapeutics reports positive initial results from the ongoing Phase 1b PIONEER trial of pociredir in sickle cell disease. The
SoundHound AI (NASDAQ: SOUN) is a small company with a $5 billion market cap, but its revenue is growing at
Federal Reserve Chair Jerome Powell is expected to push through another quarter-point interest-rate cut, despite concerns among policymakers about high
In a global Phase 3 trial, gotistobart showed promising results in patients with squamous non-small cell lung cancer. The study
Der selektive Treg-Modulatorkandidat Gotistobart zeigte in einer globalen, klinischen Phase-3-Studie eine Verringerung des Sterberisikos um mehr als die Hälfte im
The AI revolution is in full swing with companies investing heavily in AI chatbots and agents, leading to a rush
The S&P 500 is up 26% in 2024, closing the year with strong gains. Retail landscape and falling interest rates
Rocket Lab, a key player in the small-satellite launch market, plans to launch its medium-lift Neutron rocket in the first
